The DOI matches its Crossref record; 298 of the 298 references it cites were found in a registry or an index.
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Open accessAbstract
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD) considering the disease as a continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible to identify the disease even at the preclinical stage before the occurrence of the first clinical symptoms. This preclinical stage of AD has become a major research focus as the field postulates that early intervention may offer the best chance of therapeutic success. To date, very little evidence is established on this “silent” stage of the disease. A clarification is needed about the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage. This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This could explain why part of the risk factors for cardiovascular disease are in common with AD, including hypertension, dyslipidemia, diabetes, obesity, dietary factors, smoking, and physical activity (Figure 1B).”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, lifestyle is also an important risk factor, where intellectual, physical, and social activities, as well as diet, may help to prevent AD [1,22,100,101,102,103].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, the disease is now regarded as a continuum rather than three distinct clinically defined entities [15].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“While differences remain, IWG 2016 and the NIA research framework are aligned on the key issue that the combination of an abnormal Aβ and tau biomarker constitutes AD regardless of cognitive symptoms, and thus AD is a biologically defined entity throughout its continuum.”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
In the citing paper
“Furthermore, drug development research for AD has become more complicated as preclinical and prodromal AD populations are potentially included in current trials, as well as traditionally included populations of all the clinical stages of AD dementia.38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“Although the use of clinical trial simulators is not frequent in recent research,38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“This asymptomatic phase of AD (AsymAD) is currently considered a preclinical stage of the disease [27, 28].”
From Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“From the tau protein perspective, one study showed that alterations in CSF levels of p-tau may precede those of Ab [57], which correlates with postmortem evidence showing the presence of neurofibrillary tangles in the entorhinal cortex and in hippocampal-related structures [58,59] as the first neuropathologic event in…”
ResultCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,003
Gatchel, J. R., Donovan, N. J., Locascio, J. J., Becker, J. A., Rentz, D. M., Sperling, R. A., Johnson, K. A., & Marshall, G. A. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.12.017 · Cited by 43
Self-citationQuevenco, F. C., Preti, M. G., Bergen, J. M. G. V., Hua, J., Wyss, M., Li, X., Schreiner, S. J., Steininger, S. C., Meyer, R., Meier, I. B., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0249-7 · Cited by 41
Castrillo, J. I., Lista, S., Hampel, H. J., & Ritchie, C. W. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_3 · Cited by 44
Self-citationfor the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Drzezga, A. E., Altomare, D., Festari, C., Arbizu, J., Orini, S., Herholz, K., Nestor, P. J., Agosta, F., Bouwman, F. H., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4032-1 · Cited by 43
Self-citationIhle, A., Ghisletta, P., Ballhausen, N., Fagot, D., Vallet, F., Baeriswyl, M., Sauter, J., Oris, M., Maurer, J., & Kliegel, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.10.013 · Cited by 43
Iulita, M. F., Ganesh, A., Pentz, R., Aguilar, L. F., Gubert, P., Ducatenzeiler, A., Christie, S., Wilcock, G. K., & Cuello, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180970 · Cited by 45
Parra, M. A., Calia, C., García, A. F., Olazarán, J., Hernandez-Tamames, J. A., Álvarez‐Linera, J., Sala, S. D., & GUINEA, S. B. F. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2019.03.025 · Cited by 44
Analysis of Serum miRNAs in Alzheimer’s Disease
Liu, L., Dai, W.-Z., Zhu, X., & Ma, T. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211021712 · Cited by 43
Artificial Intelligence Models in the Diagnosis of Adult-Onset Dementia Disorders: A Review
Battineni, G., Chintalapudi, N., Hossain, M. A., Losco, G., Ruocco, C., Sagaro, G. G., Traini, E., Nittari, G., & Amenta, F. (2022) · Bioengineering · doi:10.3390/bioengineering9080370 · Cited by 43
Diagnostic biomarkers in Alzheimer’s disease
Andersen, E., Casteigne, B., Chapman, W. D., Creed, A., Foster, F., Lapins, A., Shatz, R., & Sawyer, R. P. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2021.100041 · Cited by 42
Peterson, A. H., Largent, E. A., Lynch, H. F., Karlawish, J. H., & Sisti, D. A. (2022) · AJOB Neuroscience · doi:10.1080/21507740.2022.2148771 · Cited by 42
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER‐ALZ 3
Yaari, R., Holdridge, K. C., Williamson, M., Wessels, A. M., Shcherbinin, S., Kotari, V., Reiman, E. M., Tariot, P. N., Alexander, R., Langbaum, J. B. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70662 · Cited by 45
Gustavsson, A., Green, C., Jones, R. W., Förstl, H., Simsek, D., de Vulpillieres, F. D. R., Luthman, S., Adlard, N., Bhattacharyya, S., & Wimo, A. B. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.005 · Cited by 42
Alzheimer's disease markers in the aged sheep (Ovis aries)
Reid, S. J., Mckean, N. E., Henty, K., Portelius, E., Blennow, K., Rudiger, S. R., Bawden, C. S., Handley, R. R., Verma, P. J., Faull, R. L. M., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.020 · Cited by 42
Self-citationSánchez, S. M., Abulafia, C., Duarte-Abritta, B., Guevara, M., Castro, M. N., Drucaroff, L. J., Sevlever, G. E., Nemeroff, C. B., Vigo, D. E., Loewenstein, D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170491 · Cited by 43
Roe, C. M., Ances, B. M., Head, D. M., Babulal, G. M., Stout, S. H., Grant, E., Hassenstab, J. J., Xiong, C., Holtzman, D. M., Benzinger, T. L. S., et al. (2018) · Brain · doi:10.1093/brain/awy244 · Cited by 42
Self-citationTimmers, M., Tesseur, I. C., Bogert, J., Zetterberg, H., Blennow, K., Börjesson‐Hanson, A., Baquero, M., Boada, M., RANDOLPH, C. C., Tritsmans, L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.016 · Cited by 43
Self-citationInitiative, A. D. N., Petrone, P., Casamitjana, A., Falcón, C., Artigues, M., Operto, G., Cacciaglia, R., Molinuevo, J. L., Vilaplana, V., & Gispert, J. D. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0526-8 · Cited by 42
Self-citationMarongiu, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00242 · Cited by 47
Plasma lipocalin‐2 levels in the preclinical stage of Alzheimer's disease
Eruysal, E., Ravdin, L., Kamel, H., Iadecola, C., & Ishii, M. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.004 · Cited by 42
Balance and Mobility Performance Along the Alzheimer’s Disease Spectrum
Yoon, B., Choi, S. H., Jeong, J. H., Park, K. W., Kim, E., Hwang, J., Jang, J., Kim, H. J., Hong, J. Y., Lee, J., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190601 · Cited by 42
Detection of Alzheimer's Disease using cortical diffusion tensor imaging
Torso, M., Bozzali, M., Zamboni, G., Jenkinson, M., Chance, S. A., & Initiative, A. D. N. (2020) · Human Brain Mapping · doi:10.1002/hbm.25271 · Cited by 42
A machine learning approach to screen for preclinical Alzheimer's disease
Gaubert, S., Houot, M., Raimondo, F., Ansart, M., Corsi, M., Naccache, L., Sitt, J. D., Habert, M., Dubois, B., Fallani, F. D. V., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.024 · Cited by 43
Self-citationRoss, A. B., Shertukde, S. P., Livingston Staffier, K., Chung, M., Jacques, P. F., & McKeown, N. M. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.003 · Cited by 41
Liang, W., Zhang, K., Cao, P., Liu, X., Yang, J., & Zai͏̈ane, O. R. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104935 · Cited by 42
Gao, F. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.110017 · Cited by 42
Jeong, S. H., Cha, J., Park, M., Jung, J. H., Ye, B. S., Sohn, Y. H., Chung, S. J., & Lee, P. H. (2022) · Neurology · doi:10.1212/wnl.0000000000200989 · Cited by 41
Transcranial magnetic stimulation: Emerging biomarkers and novel therapeutics in Alzheimer’s disease
Koch, G., Martorana, A., & Caltagirone, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134355 · Cited by 40
Paek, E. J., Murray, L. L., & Newman, S. D. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00073 · Cited by 42
Inflammaging in Endemic Areas for Infectious Diseases
Batista, M. A., Calvo-Fortes, F., Silveira‐Nunes, G., Camatta, G. C., Speziali, E., Turroni, S., Teixeira‐Carvalho, A., Martins‐Filho, O. A., Neretti, N., Maioli, T. U., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579972 · Cited by 43
Zhaoyang, R., Sliwinski, M. J., Martire, L. M., Katz, M. J., & Scott, S. (2021) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbab019 · Cited by 44
Lin, F. V., Wang, X., Wu, R., Rebok, G. W., Chapman, B. P., & Initiative, T. A. D. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161278 · Cited by 41
Ethical Considerations in Dementia Diagnosis and Care
Chiong, W., Tsou, A. Y., Simmons, Z., Bonnie, R. J., Russell, J. A., Busl, K. M., CONWIT, R. A., Cruz‐Flores, S., Epstein, L. G., Graf, W. D., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012079 · Cited by 46
Sadeghi, I., Gispert, J. D., Palumbo, E., Muñoz-Aguirre, M., Wucher, V., D’Argenio, V., Santpere, G., Navarro, A., Guigó, R., & Vilor‐Tejedor, N. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.037 · Cited by 42
Gehlot, P., Kumar, S., Vyas, V. K., Choudhary, B. S., Sharma, M., & Malik, R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117047 · Cited by 40
Biomarkers: Role and Scope in Neurological Disorders
Sharma, V., Singh, T. G., Mehta, V., & Mannan, A. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03873-4 · Cited by 46
Navigating Early Alzheimer's Diagnosis: A Comprehensive Review of Diagnostic Innovations
Juganavar, A., Joshi, A., & Shegekar, T. (2023) · Cureus · doi:10.7759/cureus.44937 · Cited by 47
Lista, S., Santos‐Lozano, A., Emanuele, E., Mercuri, N. B., Gabelle, A., López‐Ortiz, S., Martín-Hernández, J., Maisto, N., Imbimbo, C., Caraci, F., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02376-6 · Cited by 44
Self-citationEmrani, S., & Sundermann, E. E. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101184 · Cited by 53
Racine, A. M., Fong, T. G., Travison, T. G., Jones, R. N., Gou, Y., Vasunilashorn, S. M., Marcantonio, E. R., Alsop, D. C., Inouye, S. K., & Dickerson, B. C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.010 · Cited by 40
Hernández, M. D. C. V., Clark, R., Wang, S., Guazzo, F., Calia, C., Pattan, V., Starr, J. M., Sala, S. D., & Parra, M. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102158 · Cited by 40
Leng, M., Yin, H., Zhang, P., Jia, Y., Hu, M., Li, G., Wang, C., & Chen, L. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001137 · Cited by 42
Jiao, F., Yi, F., Wang, Y., Zhang, S., Guo, Y., Du, W., Gao, Y., Ren, J., Zhang, H., Liu, L., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00212 · Cited by 40
Norton, D. J., Parra, M. A., Sperling, R. A., Baena, A. Y., Guzmán‐Vélez, E., Jin, D. S., Andrea, N., Khang, J., Schultz, A. P., Rentz, D. M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00660-z · Cited by 40
Self-citationDiagnostic value of amyloid-PET and tau-PET: a head-to-head comparison
Altomare, D., Caprioglio, C., Assal, F., Allali, G., Mendes, A., Ribaldi, F., Ceyzériat, K., Martins, M., Tomczyk, S., Stampacchia, S., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05246-x · Cited by 40
Self-citationZhang, X., Lan, X., Chen, C., Ren, H., & Guo, Y. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.723715 · Cited by 43
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Atlante, A., Amadoro, G., Latina, V., & Valenti, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226742 · Cited by 40
Villain, N., & Michalon, R. (2024) · European Journal of Neurology · doi:10.1111/ene.16302 · Cited by 43
Salerno, M., & Porqueras, D. S. D. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.018 · Cited by 41
Yan, L., Liu, C. Y., Wong, K. P., Huang, S., Mack, W. J., Jann, K., Coppola, G., Ringman, J. M., & Wang, D. J. J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.12.003 · Cited by 39
Cabinio, M., Saresella, M., Piancone, F., LaRosa, F., Marventano, I., Guerini, F. R., Nemni, R., Baglio, F., & Clerici, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180250 · Cited by 39
Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia
Dounavi, M., Mak, E., Wells, K., Ritchie, K. A., Ritchie, C. W., Su, L., & O'Brien, J. T. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.006 · Cited by 39
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 41
Giorgio, J., Jagust, W. J., Baker, S. L., Landau, S. M., Peter Tiňo, B., Kourtzi, Z., & Initiative, A. D. N. (2022) · Nature Communications · doi:10.1038/s41467-022-28795-7 · Cited by 40
Haque, R. U., Manzanares, C. M., Brown, L., Pongos, A. L. A., Lah, J. J., Clifford, G. D., & Levey, A. I. (2019) · Learning & Memory · doi:10.1101/lm.048124.118 · Cited by 41
Chen, L., Cao, H., Wu, X., Xu, X., Ji, X., Wang, B., Zhang, P., & Li, H. (2022) · Geriatric Nursing · doi:10.1016/j.gerinurse.2022.09.005 · Cited by 39
FSH-blocking therapeutic for osteoporosis
Gera, S., Kuo, T., Gumerova, A. A., Korkmaz, F., Sant, D., DeMambro, V., Sudha, K., Padilla, A., Prévot, G., Munitz, J., et al. (2022) · eLife · doi:10.7554/elife.78022 · Cited by 40
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Parra, M. A., Calia, C., Pattan, V., & Sala, S. D. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01082-9 · Cited by 39
Tufail, A. B., Ullah, I., Rehman, A. U., Khan, R. A., Khan, M. A., Ma, Y., Khokhar, N. H., Sadiq, M. T., Khan, R., Shafiq, M., et al. (2022) · Sustainability · doi:10.3390/su142214695 · Cited by 38
Huang, G., Li, R., Bai, Q., & Alty, J. (2023) · Health Information Science and Systems · doi:10.1007/s13755-023-00231-0 · Cited by 40
de Oliveira, R. M. W., de Oliveira, C. L., Guimarães, F. S., & Campos, A. C. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.11 · Cited by 38
Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
Flemmig, J., Zámocký, M., & Alia, A. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235021 · Cited by 38
Detecting Alzheimer’s Disease from Continuous Speech Using Language Models
Guo, Z., Ling, Z.-H., & Li, Y. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190452 · Cited by 37
Foster, C. M., Kennedy, K. M., Hoagey, D. A., & Rodrigue, K. M. (2019) · Hippocampus · doi:10.1002/hipo.23133 · Cited by 41
Souza‐Talarico, J. N., Suemoto, C. K., Santos, I. S., Griep, R. H., Yamaguti, S. T. F., Lotufo, P. A., & Benseñor, I. M. (2019) · Stress and Health · doi:10.1002/smi.2906 · Cited by 41
Volunteering, polygenic risk for Alzheimer's disease, and cognitive functioning among older adults
Han, S. H., Roberts, J. S., Mutchler, J. E., & Burr, J. A. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.112970 · Cited by 38
Facchinetti, R., Valenza, M., Bronzuoli, M. R., Menegoni, G., Ratano, P., Steardo, L., Campolongo, P., & Scuderi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113802 · Cited by 38
PET Agents in Dementia: An Overview
van Waarde, A., Marcolini, S., Deyn, P. P. D., & Dierckx, R. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.008 · Cited by 39
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
Alves, S. S., da Silva-Júnior, R. M. P., Servilha‐Menezes, G., Homolak, J., Šalković‐Petrišić, M., & Garcia‐Cairasco, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210234 · Cited by 39
Gao, Y., Liu, J., Wang, J., Liu, Y., Zeng, L., Ge, W., & Ma, C. (2022) · Brain Pathology · doi:10.1111/bpa.13047 · Cited by 35
Dulewicz, M., Kulczyńska‐Przybik, A., Mroczko, P., Kornhuber, J., Lewczuk, P., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158598 · Cited by 38
Sabbath, E. L., Andel, R., Zins, M., Goldberg, M., & Berr, C. (2016) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103352 · Cited by 37
Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment
Montoliu‐Gaya, L., & Villegas, S. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.11 · Cited by 39
Early Prediction of Alzheimer’s Disease Using Null Longitudinal Model-Based Classifiers
Gavidia‐Bovadilla, G., Kanaan-Izquierdo, S., Mataró, M., Perera-Lluna, A., & Initiative, A. D. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168011 · Cited by 37
Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer’s Disease
Chiesa, P. A., Cavedo, E., Lista, S., Thompson, P. M., & Hampel, H. J. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.06.002 · Cited by 35
Self-citationStudy partners should be required in preclinical Alzheimer’s disease trials
Grill, J. D., & Karlawish, J. H. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0327-x · Cited by 36
He, Z., Elbaz, A., Gao, B., Zhang, J., Su, E., & Gu, Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701306 · Cited by 37
Ansart, M., Epelbaum, S., Gagliardi, G. P., Olivier Colliot, A., Dormont, D., Dubois, B., Hampel, H. J., Durrleman, S., & Initiative, A. D. N. (2019) · Statistical Methods in Medical Research · doi:10.1177/0962280218823036 · Cited by 36
Self-citationAmyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice
Sos, K. E., Mayer, M. I., Takács, V. T., Major, A., Bardóczi, Z., Beres, B. M., Szeles, T., Saito, T., Saido, T. C., Mody, I., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233700 · Cited by 37
López‐Cuenca, I., de Hoz, R., Salobrar‐García, E., Elvira‐Hurtado, L., Rojas, P., Fernández‐Albarral, J. A., Barabash, A., Salazar, J. J., Ramirez, A. I., & Ramirez, J. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061728 · Cited by 37
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
Gaetani, L., Parnetti, L., Calabresi, P., & Filippo, M. D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.672954 · Cited by 37
Kucikova, L., Goerdten, J., Dounavi, M., Mak, E., Su, L., Waldman, A. D., Danso, S., Terrera, G. M., & Ritchie, C. W. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.024 · Cited by 42
Pelowski, M. J., Spee, B. T. M., Arató, J., Dörflinger, F., Ishizu, T., & Richard, A. (2022) · Physics of Life Reviews · doi:10.1016/j.plrev.2022.07.005 · Cited by 38
RetractedZotcheva, E., Bratsberg, B., Strand, B. H., Jugessur, A., Engdahl, B., Bowen, C. E., Selbæk, G., Kohler, H., Harris, J. R., Weiss, J., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100721 · Cited by 38
Llano, D. A., Devanarayan, P., & Devanarayan, V. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000328 · Cited by 35
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201534 · Cited by 37
A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data
Tan, W. Y., Hargreaves, C. A., Chen, C., & Hilal, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220776 · Cited by 37
Fernández, S. S. M., Ivanauskas, T. M., & Ribeiro, S. M. L. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.015 · Cited by 36
Healthy aging: A bibliometric analysis of the literature
Gu, Y., Bai, J., Chen, X., Wu, W., Liu, X., & Tan, X. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.11.014 · Cited by 40
ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics
Fruijtier, A. D., Visser, L. N. C., van Maurik, I. S., Zwan, M. D., Bouwman, F. H., van der Flier, W. M., & Smets, E. M. A. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0531-y · Cited by 36
Jiang, J., Wang, M., Alberts, I., Sun, X., Li, T., Rominger, A., Zuo, C., Han, Y., & Shi, K. (2022) · doi:10.48350/175943 · Cited by 36
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Jeremic, D., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102003 · Cited by 36
Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
Gaur, A., Rivet, L., Mah, E., Bawa, K. K., Gallagher, D., Herrmann, N., & Lanctôt, K. L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102046 · Cited by 37
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Initiative, A. D. N., Pascoal, T. A., Mathotaarachchi, S. S., Shin, M., Park, A. Y., Mohades, S., Benedet, A. L., Kang, M. S., Massarweh, G., Soucy, J., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3933-3 · Cited by 34
Self-citationBos, I., Vos, S. J. B., Jansen, W. J., Vandenberghe, R. R., Gabel, S., Estanga, A., Ecay‐Torres, M., Tomassen, J., den Braber, A., Lleó, A., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00193 · Cited by 35
Self-citationRossetto, F., Baglio, F., Massaro, D., Alberoni, M., Nemni, R., Marchetti, A., & Castelli, I. (2020) · Behavioural Neurology · doi:10.1155/2020/5204927 · Cited by 38
Schoentgen, B., Gagliardi, G. P., & Defontaines, B. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01814 · Cited by 44
Astrocyte subtype-specific approach to Alzheimer's disease treatment
Sarkar, S., & Biswas, S. C. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104956 · Cited by 35
Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
Briganti, S., Truglio, M., Angiolillo, A., Lombardo, S., Leccese, D., Camera, E., Picardo, M., & Costanzo, A. D. (2021) · Metabolites · doi:10.3390/metabo11120819 · Cited by 36
Torres-Simón, L., Doval, S., Nebreda, A., Llinas, S. J., Marsh, E. B., & Maestú, F. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103040 · Cited by 52
Metadata
- Authors
- Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., Broich, K., Cavedo, E., Crutch, S., Dartigues, J., Duyckaerts, C., Epelbaum, S., Frisoni, G. B., Gauthier, S., Genthon, R., Gouw, A. A., Habert, M., Holtzman, D. M., Kivipelto, M., Lista, S., Molinuevo, J., O'Bryant, S. E., Rabinovici, G. D., Rowe, C., Salloway, S., Schneider, L. S., Sperling, R., Teichmann, M., Carrillo, M. C., Cummings, J., Jack, C. R., & Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2. W. D.
- Affiliations
- Sorbonne Université (FR)
- University of British Columbia (CA)
- Amsterdam Neuroscience (NL)
- University of Southern California (US)
- Université Toulouse III - Paul Sabatier (FR)
- Institut du Cerveau (FR)
- Centre National de la Recherche Scientifique (FR)
- Institute for Integrative and Experimental Genomics (DE)
- Sahlgrenska University Hospital (SE)
- Federal Institute for Drugs and Medical Devices (DE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- UCL Queen Square Institute of Neurology (GB)
- Université de Bordeaux (FR)
- University of Geneva (CH)
- Douglas Mental Health University Institute (CA)
- Fondation pour la Recherche sur Alzheimer Hôpital Pitié‐Salpêtrière Paris France
- Washington University in St. Louis (US)
- Karolinska University Hospital (SE)
- AXA Research Fund (FR)
- Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain
- Center for Alzheimer's & Neurodegenerative Disease Research University of North Texas Health Science Center TX USA
- University of California, San Francisco (US)
- The University of Melbourne (AU)
- Brown University (US)
- Brigham and Women's Hospital (US)
- The Alzheimer's Association Division of Medical & Scientific Relations Chicago USA
- Cleveland Clinic (US)
- Department of Radiology Mayo Clinic Rochester MN USA
- Corresponding author
- Dubois, Bruno
- ORCID
- Dubois, Bruno
- Hampel, Harald
- Feldman, Howard H.
- Scheltens, Philip
- Andrieu, Sandrine
- Bakardjian, Hovagim
- Benali, Habib
- Bertram, Lars
- Blennow, Kaj
- Broich, Karl
- Cavedo, Enrica
- Crutch, Sebastian
- Dartigues, Jean‐François
- Duyckaerts, Charles
- Epelbaum, Stéphane
- Frisoni, Giovanni B.
- Gauthier, Serge
- Gouw, Alida A.
- Habert, Marie‐Odile
- Holtzman, David M.
- Kivipelto, Miia
- Lista, Simone
- Rabinovici, Gil D.
- Rowe, Christopher
- Salloway, Stephen
- Schneider, Lon S.
- Sperling, Reisa
- Teichmann, Marc
- Cummings, Jeffrey
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03
- Volume
- 12
- Issue
- 3
- Pages
- 292-323
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC6417794
- OpenAlex
- W2309442902
- Cited by
- 1,925
- References
- 298
- Citations by year
- 2026: 115 · 2025: 176 · 2024: 244 · 2023: 245 · 2022: 247 · 2021: 244 · 2020: 176 · 2019: 157 · 2018: 161 · 2017: 112 · 2016: 47
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- AXA Research Fund
- National Institute on Aging
- Alzheimer's Association
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- preclinical Alzheimer's disease, Alzheimer's disease continuum
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
